Large variations in serum MMP-3 levels observed in the cancer patient group in the present study are attributable to the increased number of malignant epithelial cells, which potentially compromised the decreased expression of MMP-3 in CAFs at different levels. The gene discussed is MMP3; the disease is cancer.